# Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT

> **NCT05084079** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 56 (estimated)

## Conditions studied

- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Glucose Metabolism Disorders
- Metabolic Disease
- Endocrine System Diseases

## Interventions

- **DRUG:** CSII with formula-based initial insulin regimen
- **DRUG:** CSII with weight-based initial insulin regimen

## Key facts

- **NCT ID:** NCT05084079
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084079, "Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05084079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*